Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168,674 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of CMAB008 Compared with Innovator Infliximab in Patients with Moderate-to-Severe Rheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study.
Ye H, Liu S, Xu J, Chai K, He D, Fang Y, Xie Q, Liu H, Liu Y, Hua B, Hu J, Zhang Z, Zhou M, Zhao D, Li Y, Jiang Z, Wang M, Li J, Zhang Z, Li X, Li Y, Sun E, Bi L, Wei W, Tie N, He L, Huang X, Zhang Y, Huang Q, Wang X, Liu X, Li J, Su Y. Ye H, et al. Among authors: li y, li j, li x. Rheumatol Ther. 2023 Jun;10(3):757-773. doi: 10.1007/s40744-023-00544-2. Epub 2023 Mar 25. Rheumatol Ther. 2023. PMID: 36964872 Free PMC article.
Comparison of the efficacy and safety of the adalimumab biosimilar TQ-Z2301 and adalimumab for the treatment of Chinese patients with active ankylosing spondylitis: a multi-center, randomized, double-blind, phase III clinical trial.
Li J, Xue Z, Wu Z, Bi L, Liu H, Wu L, Liu S, Huang X, Wang Y, Zhang Y, Qi W, He L, Dai L, Sun L, Li X, Shuai Z, Zhao Y, Wang Y, Xu J, Zhang H, Yu H, Chen X, Bao C. Li J, et al. Among authors: li x. Clin Rheumatol. 2022 Oct;41(10):3005-3016. doi: 10.1007/s10067-022-06199-8. Epub 2022 Jun 8. Clin Rheumatol. 2022. PMID: 35676450 Clinical Trial.
168,674 results
You have reached the last available page of results. Please see the User Guide for more information.